Patent EP-1688416-A1 (EP)
Inventor: EDMONDS-ALTS XAVIER
IPC: A61P1/12
Filed: 1996-01-30
Abstract: Heterocyclic compounds of formula (I) and their acid addition salts are new. A = (A1) -O-CO-; (A2) -CH2O-CO; (A3) -O-CH2-CO-; (A4) -O-CH2-CH2-; (A5) -N(R1)-CO-; (A6) -N(R1)-CO-CO-; (A7) -N(R1)-CH2-CH2-; or (A8) -O-CH2-; R1 = H or 1-4C alkyl; m = 2 or 3; Ar1 = phenyl opt. substd. by one or more of halo, OH, 1-4C alkyl, 1-4C alkoxy, CF3 or methylene dioxyl; thienyl, benzothienyl, naphthyl, imidazolyl or pyridyl, all opt. substd. by one halo; indolyl opt. N-substd. by 1-4C alkyl or benzyl; or biphenyl; T = -CH2-Z; -CH(C6H5)2, -C(C6H5)3, or, when A = A4, A7 or A8, T may further be -CO-B-Z; B = a direct bond or methylene; Z = opt. substd. mono-, di- or tri-cyclic aromatic or heteroaromatic gp.; Am = a group Am1-Am4; J1 = Ar2-N(R2)-CH, Ar2(CH2)n-C(R3) or R14-C(R3); Ar2 = pyridyl; phenyl opt. substd. by one or more of halo, OH, 1-4C alkyl, 1-4C alkoxy, CF3, NO2, or methylenedioxy; thienyl, pyrimidyl or imidazolyl, all opt. substd. by 1-4C alkyl; R2 = H, 1-7C alkyl, benzyl, formyl or 1-7C alkylcarbonyl; n = 0 or 1; R3 = H, 1-7C alkyl, formyl, 1-7C alkylcarbonyl, CN, -(CH2)q-OH, -(CH2)q-O-(1-7C alkyl), -(CH2)q-OCHO-, -(CH2)q-OCOR17, -(CH2)q-OCONH-(1-7C alkyl), -NR4R5, -(CH2)qNR6C(=W1)R7, -(CH2)qNR6COOR8, -(CH2)qNR6SO2R9, -(CH2)qNR6C(=W1)NR10R11, -CH2-NR12R13, -CH2CH2-NR12R13, -COOH, 1-7C alkoxycarbonyl, -C(=W1)NR10R11, -CH2COOH, 1-7C alkoxycarbonylmethyl, -CH2-C(=W1)NR10R11, -O-CH2CH2-O-R18, -NR6COCOR19, -CO-NR20-NR21R22, or a gp. of formula (i) or (ii), or a double bond; q = 0, 1 or 2; W1 = O or S; R4, R5 = H or 1-7C alkyl, or R5 may further be 3-7C cycloalkyl, methyl, benzyl or phenyl; or NR4R5 = azetidine, pyrrolidine, piperidine, morpholine, thiomorpholine, perhydroazepine, piperazine or 4-(1-4C alkyl)piperazine; R6 = H or 1-7C alkyl; R7 = H, 1-7C alkyl, vinyl, phenyl, benzyl, pyridyl; 3-7C cycloalkyl opt. substd. by methyl(s), furyl, thienyl, pyrrolyl or imidazolyl; or R6+R7 = (CH2)p; p = 3 or 4; R8 = 1-7C alkyl or phenyl; R9 = 1-7C alkyl; amino opt. substd. by 1 or 2, 1-7C alkyl; phenyl opt. substd. by one or more of halo, 1-7C alkyl, 1-7C alkoxy, CF3, OH, carboxy, 1-7C alkoxycarbonyl, 1-7C alkoxycarbonyloxy, CN, NO2, or amino opt. substd. by 1 or 2, 1-7C alkyl; R10, R11 = H or 1-7C alkyl; or R11 may further be 3-7C cycloalkylmethyl, 3-7C cycloalkyl, OH, 1-4C alkoxy, benzyl or phenyl; or NR10R11 = azetidine, pyrrolidine, piperidine, morpholine, thiomorpholine, or perhydroazepine; R12, R13 = H or 1-7C alkyl; or R13 may further be 3-7C cycloalkylmethyl or benzyl; R17 = 1-7C alkyl; or 3-7C cycloalkyl opt. substd. by one or more Me;, phenyl; or pyridyl; R18 = H, 1-7C alkyl, formyl, or 1-7C alkylcarbonyl; R19 = 1-4C alkoxy; R20-R23 = H or 1-7C alkyl; or NR21R22 = pyrrolidine, piperidine or morpholine; R24, R25 = H or 1-7C alkyl; or R25 may further be formyl or 1-7C alkylcarbonyl; R14 = 1-7C alkyl, 3-7C cycloalkyl, and, when R3 = H, R14 may further be -CONR15R16, and when R3 = H, CN, COOH, 1-7C alkoxycarbonyl or -C(=W1)NR10R11 then R14 may be -NR15R16; R15, R16 = 1-7C alkyl; or NR15R16 = azetidine, pyrrolidine, piperidine, morpholine, thiomorpholine, or perhydroazepine; J2 = Ar3N(R2)-CH or Ar3(CH2)n-CH; Ar3 = phenyl opt. substd. by halo, OH, 1-4C alkyl, 1-4C alkoxy, or CF3; Q = 1-6C alkyl or benzyl, this being in the axial or equatorial configuration; and X- = an anion.